Article
Predicting Bevirimat resistance of HIV-1 from genotype.
BMC bioinformatics - 20 Jan 2010
Heider Dominik, Verheyen Jens, Hoffmann Daniel
Abstract excerpt
BACKGROUND: Maturation inhibitors are a new class of antiretroviral drugs. Bevirimat (BVM) was the first substance in this class of inhibitors entering clinical trials. While the inhibitory function of BVM is well established, the molecular mechanisms of action and resistance are not well underst...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
